Model for diabetic patients | Treatments | RD | LL | UL | NNT | LL | UL |
 ATE | RAAS1 vs non-RAAS | 0.062 | −0.037 | 0.161 | 16.1 | −9.5 | 41.7 |
 | RAAS2 vs non-RAAS | −0.059 | −.0129 | 0.0112 | −16.9 | −36.9 | 3.18 |
 |  | Risk | LL | UL | RR | LL | UL |
 POM | Non-RAAS | 0.681 | 0.659 | 0.704 | 1 |  |  |
 | RAAS1 | 0.743 | 0.647 | 0.839 | 1.091 | 0.945 | 1.236 |
 | RAAS2 | 0.622 | 0.555 | 0.689 | 0.913 | 0.810 | 1.016 |
Model for non-diabetic patients | Treatments | RD | LL | UL | NNT | LL | UL |
 ATE | RAAS1 vs non-RAAS | 0.124 | −0.059 | 0.306 | 8.1 | −3.8 | 19.9 |
 | RAAS2 vs non-RAAS | −0.121 | −0.333 | 0.092 | −8.3 | −22.9 | 6.3 |
 |  | Risk | LL | UL | RR | LL | UL |
 POM | Non-RAAS | 0.596 | 0.576 | 0.617 | 1 |  |  |
 | RAAS1 | 0.719 | 0.539 | 0.901 | 1.209 | 0.909 | 1.509 |
 | RAAS2 | 0.475 | 0.264 | 0.687 | 0.798 | 0.435 | 1.162 |